Artificial disc replacement technology has made significant growth in 2023. Here are seven key developments to know:
1. Todd Lanman, MD, a neurosurgeon at ADR Spinal Restoration Center in Beverly Hills, Calif., has performed a breakthrough case in motion restoration for the spine. Dr. Lanman has presented a series of cases in which patients with failed and solid spinal fusions had successful total disc replacements, something previously considered impossible.
2. Centinel Spine finished enrollment for a 2-level Investigational Device Exemption trial for the Prodisc C Vivo and Prodisc C SK disc replacement devices. The trial will include 431 patients across 29 sites in the U.S. The IDE trial is the first to allow surgeons to select from two different disc replacement devices to treat each level.
3. DOCS Health of Los Angeles completed enrollment as primary investigators in Centinel Spine's 2-level SMART disc replacement clinical study. The study will evaluate the Prodisc C Vivo and Prodisc C SK devices in patients with symptomatic cervical disc disease.
4. Centinel Spine's global fusion business will be acquired by Silony Medical. Centinel Spine is offloading the fusion segment to exclusively focus on total disc replacement.
5. The FDA gave ZimVie's Mobi-C cervical disc hybrid investigational device exemption. The approval paves the way for ZimVie to enroll U.S. patients in a study that will assess cervical disc replacement adjacent to a spinal fusion.
6. The NuVasive Simplify cervical disc replacement implant was found to be superior to anterior cervical discectomy fusion after five years. The five-year study found that statistically significant postoperative improvements in neck disability index and visual analog scale after two years remained through five years compared ACDF.
7. The artificial disc replacement market is expected to surpass $1.3 billion by 2030, according to Vantage Market Research.